Search Within

Nicole Lamanna

Formats
  1. Meeting Abstract (39)
  2. Journal Article (19)
  3. Book Section (2)
Groups
  1. Center for Hematologic Malignancies (35)
  2. Department of Medicine (35)
  3. Hematologic Malignancies, Division of (35)
  4. Adult Leukemia (23)
  5. GSK Faculty (19)
  6. Hematologic Malignancies Research (19)

More Groups

People
  1. Mark Weiss (24)
  2. Peter Maslak (18)
  3. Joseph Jurcic (17)
  4. David Scheinberg (13)
  5. Mark Heaney (12)
  6. Renier Brentjens (12)

More People

Years
  1. 2015 (1)
  2. 2014 (7)
  3. 2013 (7)
  4. 2012 (9)
  5. 2011 (4)
  6. 2010 (2)

More Years

Publications
  1. Blood (19)
  2. Journal of Clinical Oncology (15)
  3. Current Hematologic Malignancy Reports (5)
  4. Current Oncology Reports (2)
  5. Haematologica (2)
  6. Advances in Pharmacology (1)

More Publications

Publishers
  1. American Society of Hematology (19)
  2. American Society of Clinical Oncology (15)
  3. Springer (7)
  4. American Association for Cancer Research (2)
  5. CMP Healthcare Media (2)
  6. Elsevier Inc. (2)

More Publishers

Results (60)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Furman, R. R.; Sharman, J. P.; Coutre, S. E.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia
    Journal Article

    Pashos, C. L.; Flowers, C. R.; Kay, N. E.; Weiss, M.; Lamanna, N.; Farber, C.; Lerner, S.; Sharman, J.; Grinblatt, D.; Flinn, I. W.; more...
    Supportive Care in Cancer (2013)

    Fulltext@MSK | Save
  • Immunophenotypic transformation in CLL/SLL patients
    Meeting Abstract

    Wu, X.; Kishtagari, A.; Lamanna, N.; Arcila, M.; Feldstein, J.
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Immunophenotypic transformation in CLL/SLL patients
    Meeting Abstract

    Wu, X.; Kishtagari, A.; Lamanna, N.; Arcila, M.; Feldstein, J.
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • Treatment of adults with acute lymphoblastic leukemia: Do the specifics of the regimen matter?: Results from a prospective randomized trial
    Journal Article

    Lamanna, N.; Heffner, L. T.; Kalaycio, M.; Schiller, G.; Coutre, S.; Moore, J.; Seiter, K.; Maslak, P.; Panageas, K.; Golde, D.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Safety and efficacy of dose escalated liposomal amphotericin B in adult leukemia patients with refractory invasive fungal infections: A single institution report
    Meeting Abstract

    Mathew, S.; Harnicar, S.; Halton, E.; Berman, E.; Brentjens, R. J.; Heaney, M. L.; Jurcic, J. G.; Lamanna, N.; Maslak, P. G.; Rosenblat, T. L.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A new paradigm in CLL: Minimizing toxicity by using the minimum effective dose (MED) of lenalidomide for older patients with CLL
    Meeting Abstract

    Lamanna, N.; Heaney, M. L.; Maslak, P. G.; Jurcic, J. G.; Rosenblat, T. L.; Noy, A.; Palomba, M. L.; Weiss, M. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Variation in health-related quality of life (HRQOL) by ECOG performance status (PS) and fatigue among patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Flowers, C.; Pashos, C. L.; Weiss, M. A.; Lamanna, N.; Farber, C. M.; Kipps, T. J.; Lerner, S.; Kay, N. E.; Sharman, J. P.; Grinblatt, D. L.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Impact of the conditioning chemotherapy on outcomes in adoptive T cell therapy: Results from a phase I clinical trial of autologous CD19-targeted T cells for patients with relapsed CLL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Stefanski, J.; He, Q.; Taylor, C.; Olszewska, M.; Wasielewska, T.; Bartido, S.; Davila, M. L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • High dose cytarabine and mitoxantrone in combination with dasatinib as active induction therapy in adult patients with Philadelphia chromosome positive (ph plus ) acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Lamanna, N.; Weiss, M.; Berman, E.; Frattini, M. G.; Heaney, M.; Jurcic, J. G.; Rosenblat, T. L.; Landau, H.; Weissbrot, H.; Maslak, P. G.
    Blood (2012)

    Fulltext@MSK | Save